PD Dr. med. Thomas Hundsberger
Klinik für Neurologie (50%)
Klinik für Hämatologie und medizinische Onkologie (50%)
Ko-Leitung Zentrum für seltene Erkrankungen Ostschweiz (ZSK-O)
Interdisziplinäre Neuro-onkologische Ambulanz
Dozentur Universität St. Gallen (HSG)
Themenblockkoordinator Nervensystem im Joint Medical Master UZH/HSG
Leitende(r) Arzt/Ärztin
Neurologie, Medizinische Onkologie und Hämatologie · Dept. III, Dept. I
Neurocognitive course at 2-year follow-up in a Swiss cohort of people with well-treated HIV
Damas J, Hundsberger T, Di Benedetto C, Rossi S, Hasse B, Schlosser L, Du Pasquier R, Darling K, Cavassini M, Schmid P, Assal F, Ledergerber B, Nadin I, Tarr P, Stoeckle M, Kunze U, Hauser C, Gutbrod K, Calmy A, and the NAMACO study group. Neurocognitive course at 2-year follow-up in a Swiss cohort of people with well-treated HIV. AIDS 2021; 35:2469-2480.
01.12.2021Neurocognitive course at 2-year follow-up in a Swiss cohort of people with well-treated HIV
01.12.2021AIDS 2021; 35:2469-2480
Damas José, Hundsberger Thomas, Di Benedetto Caroline, Rossi Stefania, Hasse Barbara, Schlosser Ladina, Du Pasquier Renaud, Darling Katharine E A, Cavassini Matthias, Schmid Patrick, Assal Frédéric, Ledergerber Bruno, Nadin Isaure, Tarr Philip E, Stoeckle Marcel, Kunze Ursi, Hauser Christoph, Gutbrod Klemens, Calmy Alexandra, and the NAMACO study group
Case report: The odyssey to the right diagnosis. Surprising glioblastoma mimics
Dorin P, Jochum W, Lauber A, Neidert M, Hundsberger T (2021). Case report: The odyssey to the right diagnosis. Surprising glioblastoma mimics.
19.11.2021Case report: The odyssey to the right diagnosis. Surprising glioblastoma mimics
19.11.2021Society for Neuro Oncology Annual Meeting 2021, Boston, MA
Dorin Patrick, Jochum Wolfram, Lauber Arno, Neidert Marian Christoph, Hundsberger Thomas
[Palliative Care in Neurology]
Hertler C, Hundsberger T. [Palliative Care in Neurology]. Praxis (Bern 1994) 2021; 110:897-901.
01.11.2021[Palliative Care in Neurology]
01.11.2021Praxis (Bern 1994) 2021; 110:897-901
Hertler Caroline, Hundsberger Thomas
Assessment of neurological function using the National Institute of Health Stroke Scale in patients with gliomas
Zeitlberger A, Desax M, Hollenstein M, Hundsberger T. Assessment of neurological function using the National Institute of Health Stroke Scale in patients with gliomas. Neurooncol Pract 2021; 8:699-705.
28.07.2021Assessment of neurological function using the National Institute of Health Stroke Scale in patients with gliomas
28.07.2021Neurooncol Pract 2021; 8:699-705
Zeitlberger Anna, Desax Marie-Claire, Hollenstein Monika, Hundsberger Thomas
Fitness-to-drive for glioblastoma patients: Guidance from the Swiss Neuro-Oncology Society (SwissNOS) and the Swiss Society for Legal Medicine (SGRM)
Hofer S, Baumert B, Läubli H, Gramatzki D, Reinert M, Pesce G, Schucht P, Frank I, Lehnick D, Weiss T, Wirsching H, Wolpert F, Roth P, Eggenberger N, Pflugshaupt T, Keller K, Imbach L, Roelcke U, Hutter G, Hundsberger T, Hertler C, Le Rhun E, Vasella F, Cordier D, Neidert M, Hottinger A, Migliorini D, Weller M. Fitness-to-drive for glioblastoma patients: Guidance from the Swiss Neuro-Oncology Society (SwissNOS) and the Swiss Society for Legal Medicine (SGRM). Swiss Med Wkly 2021; 151:w20501.
16.05.2021Fitness-to-drive for glioblastoma patients: Guidance from the Swiss Neuro-Oncology Society (SwissNOS) and the Swiss Society for Legal Medicine (SGRM)
16.05.2021Swiss Med Wkly 2021; 151:w20501
Hofer Silvia, Baumert Brigitta, Läubli Heinz, Gramatzki Dorothee, Reinert Michael, Pesce Gianfranco, Schucht Philippe, Frank Irène, Lehnick Dirk, Weiss Tobias, Wirsching Hans-Georg, Wolpert Fabian, Roth Patrick, Eggenberger Noemi, Pflugshaupt Tobias, Keller Kristina, Imbach Lukas, Roelcke Ulrich, Hutter Gregor, Hundsberger Thomas, Hertler Caroline, Le Rhun Emilie, Vasella Flavio, Cordier Dominik, Neidert Marian Christoph, Hottinger Andreas, Migliorini Denis, Weller Michael
[Home infusion therapy for Pompe disease: Recommendations for German-speaking countries]
Hahn A, Schlegel T, Ballhausen D, Lagler F, Ziegler A, Wenninger S, Löscher W, Hundsberger T, Boentert M, Lampe C, Schoser B. [Home infusion therapy for Pompe disease: Recommendations for German-speaking countries]. Fortschr Neurol Psychiatr 2021
27.04.2021[Home infusion therapy for Pompe disease: Recommendations for German-speaking countries]
27.04.2021Fortschr Neurol Psychiatr 2021
Hahn Andreas, Schlegel Thomas, Ballhausen Diana, Lagler Florian, Ziegler Andreas, Wenninger Stephan, Löscher Wolfgang, Hundsberger Thomas, Boentert Matthias, Lampe Christina, Schoser Benedikt
Pembrolizumab-Associated CD8 Vasculitic Mononeuritis Multiplex in a Patient With Mesothelioma
Baldauf M, Jörger M, Flatz L, Rodriguez R, Frank S, Felbecker A, Hundsberger T. Pembrolizumab-Associated CD8 Vasculitic Mononeuritis Multiplex in a Patient With Mesothelioma. Neurol Neuroimmunol Neuroinflamm 2021; 8
06.04.2021Pembrolizumab-Associated CD8 Vasculitic Mononeuritis Multiplex in a Patient With Mesothelioma
06.04.2021Neurol Neuroimmunol Neuroinflamm 2021; 8
Baldauf Michaela, Jörger Markus, Flatz Lukas, Rodriguez Regulo, Frank Stephan, Felbecker Ansgar, Hundsberger Thomas
[Home infusion therapy for Pompe disease: Recommendations for German-speaking countries]
Hahn A, Schlegel T, Ballhausen D, Lagler F, Ziegler A, Wenninger S, Löscher W, Hundsberger T, Boentert M, Lampe C, Schoser B. [Home infusion therapy for Pompe disease: Recommendations for German-speaking countries]. Fortschr Neurol Psychiatr 2021
09.02.2021[Home infusion therapy for Pompe disease: Recommendations for German-speaking countries]
09.02.2021Fortschr Neurol Psychiatr 2021
Hahn Andreas, Schlegel Thomas, Ballhausen Diana, Lagler Florian, Ziegler Andreas, Wenninger Stephan, Löscher Wolfgang, Hundsberger Thomas, Boentert Matthias, Lampe Christina, Schoser Benedikt
Natural ghrelin in advanced cancer patients with cachexia, a case series.
Blum D, de Wolf-Linder S, Oberholzer R, Brändle M, Hundsberger T, Strasser F. Natural ghrelin in advanced cancer patients with cachexia, a case series. J Cachexia Sarcopenia Muscle 2021; 12:506-516.
15.01.2021Natural ghrelin in advanced cancer patients with cachexia, a case series.
15.01.2021J Cachexia Sarcopenia Muscle 2021; 12:506-516
Blum David, de Wolf-Linder Susanne, Oberholzer Rolf, Brändle Michael, Hundsberger Thomas, Strasser Florian
MRI and FET-PET Predict Survival Benefit from Bevacizumab Plus Radiotherapy in Patients with Isocitrate Dehydrogenase Wild-type Glioblastoma: Results from the Randomized ARTE Trial
Wirsching H, Tabatabai G, Ochsenbein A, Roth P, Remonda L, Conen K, Caparrotti F, von Moos R, Hottinger A, Hundsberger T, Weller J, Roelcke U, Weller M. MRI and FET-PET Predict Survival Benefit from Bevacizumab Plus Radiotherapy in Patients with Isocitrate Dehydrogenase Wild-type Glioblastoma: Results from the Randomized ARTE Trial. Clin Cancer Res 2020; 27:179-188.
23.09.2020MRI and FET-PET Predict Survival Benefit from Bevacizumab Plus Radiotherapy in Patients with Isocitrate Dehydrogenase Wild-type Glioblastoma: Results from the Randomized ARTE Trial
23.09.2020Clin Cancer Res 2020; 27:179-188
Wirsching Hans-Georg, Tabatabai Ghazaleh, Ochsenbein Adrian, Roth Patrick, Remonda Luca, Conen Katrin, Caparrotti Francesca, von Moos Roger, Hottinger Andreas F, Hundsberger Thomas, Weller Jonathan, Roelcke Ulrich, Weller Michael
Fingolimod and tumor-infiltrating lymphocytes in checkpoint-inhibitor treated cancer patients
Hasan Ali O, Hundsberger T, Diem S, Müller S, Pop O, Markert E, Müller J, Moulin A, Ring S, Ackermann C, Berner F, Flatz L. Fingolimod and tumor-infiltrating lymphocytes in checkpoint-inhibitor treated cancer patients. Cancer Immunol Immunother 2020; 70:563-568.
17.08.2020Fingolimod and tumor-infiltrating lymphocytes in checkpoint-inhibitor treated cancer patients
17.08.2020Cancer Immunol Immunother 2020; 70:563-568
Hasan Ali Omar, Hundsberger Thomas, Diem Stefan, Müller Stefanie, Pop Oltin, Markert Eva, Müller Joachim, Moulin Alexandre, Ring Sandra, Ackermann Christoph Jakob, Berner Fiamma, Flatz Lukas
A contemporary perspective on the diagnosis and treatment of diffuse gliomas in adults
Roth P, Hofer S, Pesce G, Roelcke U, Mamot C, Reinert M, Schucht P, Läubli H, Hundsberger T, Hottinger A, Weller M. A contemporary perspective on the diagnosis and treatment of diffuse gliomas in adults. Swiss Med Wkly 2020; 150:w20256.
18.06.2020A contemporary perspective on the diagnosis and treatment of diffuse gliomas in adults
18.06.2020Swiss Med Wkly 2020; 150:w20256
Roth Patrick, Hofer Silvia, Pesce Gianfranco, Roelcke Ulrich, Mamot Christoph, Reinert Michael, Schucht Philippe, Läubli Heinz, Hundsberger Thomas, Hottinger Andreas F, Weller Michael
Insular Decision Criteria in Clinical Practice: Analysis of Decision-Making in Oncology
Iseli T, Plasswilm L, Sirén C, Schmidt B, Rothermundt C, Hundsberger T, Glatzer M, Panje C, Fischer G, Putora P. Insular Decision Criteria in Clinical Practice: Analysis of Decision-Making in Oncology. Oncology 2020; 98:438-444.
19.05.2020Insular Decision Criteria in Clinical Practice: Analysis of Decision-Making in Oncology
19.05.2020Oncology 2020; 98:438-444
Iseli Thomas, Plasswilm Ludwig, Sirén Charlotta, Schmidt Barbara, Rothermundt Christian, Hundsberger Thomas, Glatzer Markus, Panje Cédric, Fischer Galina, Putora Paul Martin
Akutes Karpaltunnelsyndrom durch Thrombose einer persistierenden Arteria mediana
Baumer A, Hundsberger T. Akutes Karpaltunnelsyndrom durch Thrombose einer persistierenden Arteria mediana. Swiss Medical Forum 2020; 20:86-88.
27.01.2020Akutes Karpaltunnelsyndrom durch Thrombose einer persistierenden Arteria mediana
27.01.2020Swiss Medical Forum 2020; 20:86-88
Baumer Andrea, Hundsberger Thomas
Impact of treatment decision algorithms on treatment costs in recurrent glioblastoma: a health economic study
Panje C, Putora P, Hundsberger T, Hottinger A, Roelcke U, Pesce G, Herrmann E, Matter-Walstra K. Impact of treatment decision algorithms on treatment costs in recurrent glioblastoma: a health economic study. Swiss Med Wkly 2019; 149:w20153.
02.12.2019Impact of treatment decision algorithms on treatment costs in recurrent glioblastoma: a health economic study
02.12.2019Swiss Med Wkly 2019; 149:w20153
Panje Cédric, Putora Paul Martin, Hundsberger Thomas, Hottinger Andreas F, Roelcke Ulrich, Pesce Gianfranco, Herrmann Evelyn, Matter-Walstra Klazien
Extent, impact, and predictors of diagnostic delay in Pompe disease: A combined survey approach to unveil the diagnostic odyssey
Lagler F, Karabul N, Rösler K, Hundsberger T, Gökce S, Mengel E, Hennermann J, Rohrbach M, Moder A, Huemer M. Extent, impact, and predictors of diagnostic delay in Pompe disease: A combined survey approach to unveil the diagnostic odyssey. JIMD Rep 2019; 49:89-95.
17.07.2019Extent, impact, and predictors of diagnostic delay in Pompe disease: A combined survey approach to unveil the diagnostic odyssey
17.07.2019JIMD Rep 2019; 49:89-95
Lagler Florian B, Karabul Nesrin, Rösler Kai M, Hundsberger Thomas, Gökce Seyfullah, Mengel Eugen, Hennermann Julia, Rohrbach Marianne, Moder Angelika, Huemer Martina
Comparison of recent pivotal recommendations for the diagnosis and treatment of late-onset Pompe disease using diagnostic nodes-the Pompe disease burden scale
Hundsberger T, Schoser B, Leupold D, Rösler K, Putora P. Comparison of recent pivotal recommendations for the diagnosis and treatment of late-onset Pompe disease using diagnostic nodes-the Pompe disease burden scale. J Neurol 2019; 266:2010-2017.
18.05.2019Comparison of recent pivotal recommendations for the diagnosis and treatment of late-onset Pompe disease using diagnostic nodes-the Pompe disease burden scale
18.05.2019J Neurol 2019; 266:2010-2017
Hundsberger Thomas, Schoser Benedikt, Leupold Daniela, Rösler Kai Michael, Putora Paul Martin
36-Months follow-up assessment after cessation and resuming of enzyme replacement therapy in late onset Pompe disease: data from the Swiss Pompe Registry
Scheidegger O, Leupold D, Sauter R, Findling O, Rösler K, Hundsberger T. 36-Months follow-up assessment after cessation and resuming of enzyme replacement therapy in late onset Pompe disease: data from the Swiss Pompe Registry. J Neurol 2018
19.09.201836-Months follow-up assessment after cessation and resuming of enzyme replacement therapy in late onset Pompe disease: data from the Swiss Pompe Registry
19.09.2018J Neurol 2018
Scheidegger Olivier, Leupold Daniela, Sauter Rafael, Findling Oliver, Rösler Kai Michael, Hundsberger Thomas
Bevacizumab plus hypofractionated radiotherapy versus radiotherapy alone in elderly patients with glioblastoma: the randomized, open-label, phase II ARTE trial
Wirsching H, Riklin C, Felsberg J, Roth P, Jones D, Pfister S, Rushing E, Abrey L, Reifenberger G, Held L, von Deimling A, Ochsenbein A, von Moos R, Caparrotti F, Tabatabai G, Roelcke U, Hottinger A, Jörger F, Schmid A, Plasswilm L, Schrimpf D, Mancao C, Capper D, Conen K, Hundsberger T, Weller M. Bevacizumab plus hypofractionated radiotherapy versus radiotherapy alone in elderly patients with glioblastoma: the randomized, open-label, phase II ARTE trial. Ann Oncol 2018; 29:1423-1430.
01.06.2018Bevacizumab plus hypofractionated radiotherapy versus radiotherapy alone in elderly patients with glioblastoma: the randomized, open-label, phase II ARTE trial
01.06.2018Ann Oncol 2018; 29:1423-1430
Wirsching H-G, Riklin C, Felsberg J, Roth P, Jones D T W, Pfister S, Rushing E J, Abrey L, Reifenberger G, Held L, von Deimling A, Ochsenbein A, von Moos R, Caparrotti F, Tabatabai G, Roelcke U, Hottinger A F, Jörger F, Schmid A, Plasswilm Ludwig, Schrimpf D, Mancao C, Capper D, Conen K, Hundsberger Thomas, Weller M
[A Rare Cause for Transient Aphasia after Conorary Angiography]
Schilling C, Weilenmann D, Diener S, Hundsberger T. [A Rare Cause for Transient Aphasia after Conorary Angiography]. Praxis (Bern 1994) 2018; 107:531-534.
03.04.2018[A Rare Cause for Transient Aphasia after Conorary Angiography]
03.04.2018Praxis (Bern 1994) 2018; 107:531-534
Schilling Carin, Weilenmann Daniel, Diener Suzie, Hundsberger Thomas